{"name":"EuclidSR Partners","permalink":"euclidsr-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/euclidsr-partners","homepage_url":"http://www.euclidsr.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"","number_of_employees":null,"founded_year":1970,"founded_month":10,"founded_day":1,"tag_list":"","alias_list":null,"created_at":"Fri Apr 17 16:17:04 UTC 2009","updated_at":"Fri Oct 08 05:52:18 UTC 2010","overview":"<p>Successful venture investing combines two essential components: finding opportunities with significant growth potential and helping to deliver on that potential. It requires a committed approach by experienced investors, not just to building returns but to building companies. Successful investors - armed with deep knowledge of their industries - commit time and focus in addition to capital.</p>\n\n<p>EuclidSR Partners (ESR) provides this kind of commitment - a dedicated approach to life sciences, technology and their convergence, by a highly regarded team of industry experts.</p>\n\n<p>We look to find opportunities with significant growth potential and we work to unlock that potential for our investors. ESR possesses the elements critical for success in today&#8217;s venture capital environment</p>","image":null,"offices":[],"relationships":[{"is_past":true,"title":"Principal","person":{"first_name":"Frank","last_name":"T. Lin","permalink":"frank-t-lin","image":null}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.rib-x.com/news_and_events/release_2009_01_26","source_description":"Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":25,"company":{"name":"Rib-X Pharmaceuticals","permalink":"rib-x-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/1688/41688v1-max-150x150.png"],[[250,82],"assets/images/resized/0004/1688/41688v1-max-250x250.png"],[[282,93],"assets/images/resized/0004/1688/41688v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://deals.venturebeat.com/2007/01/10/life-science-fluid-control-company-fluidigm-raises-17m-more/","source_description":"Life science fluid control company, Fluidigm, raises $17M more","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":10,"company":{"name":"Fluidigm","permalink":"fluidigm","image":{"available_sizes":[[[150,18],"assets/images/resized/0005/8990/58990v1-max-150x150.png"],[[250,31],"assets/images/resized/0005/8990/58990v1-max-250x250.png"],[[373,47],"assets/images/resized/0005/8990/58990v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/?s=Fluidigm+raises+another+%247.5M+for+stem-cell+analysis+chips","source_description":"Fluidigm raises another $7.5M for stem-cell analysis chips","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":19,"company":{"name":"Fluidigm","permalink":"fluidigm","image":{"available_sizes":[[[150,18],"assets/images/resized/0005/8990/58990v1-max-150x150.png"],[[250,31],"assets/images/resized/0005/8990/58990v1-max-250x250.png"],[[373,47],"assets/images/resized/0005/8990/58990v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}